TherapeuticsMD, Inc. (TXMD) Operating cash flow 2016–2025
TherapeuticsMD, Inc. (TXMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$2.5MFY2025 · since FY2016: -$69.1M → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5M | +109.7% |
| FY2024 | $1.2M | +105.1% |
| FY2023 | -$23.1M | -346.6% |
| FY2022 | $9.4M | +106.6% |
| FY2021 | -$142.7M | +10.5% |
| FY2020 | -$159.5M | +3.8% |
| FY2019 | -$165.7M | -55.1% |
| FY2018 | -$106.8M | -40.3% |
| FY2017 | -$76.2M | -10.1% |
| FY2016 | -$69.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TXMD financial trends
TXMD RevenueTXMD Net incomeTXMD Net marginTXMD Gross profitTXMD Gross marginTXMD Operating incomeTXMD Operating marginTXMD Free cash flowTXMD Capital expendituresTXMD Return on equityTXMD Stock buybacksTXMD Dividends paidTXMD Total assetsTXMD Total liabilitiesTXMD Shareholders’ equityTXMD overview →